Deprescribe with Shawn Gill

#5 - A Case Study on Deprescribing Desvenlafaxine.


Listen Later

Welcome to the fifth episode of Deprescribe with Shawn.

Today’s episode is a recording of a case presentation I gave for the University of British Columbia’s Therapeutics Initiative, in July 2024. I presented a patient case on deprescribing desvenlafaxine (brand name: Pritiq) using hyperbolic tapering.

To learn more about my presentation with Therapeutics Initiative, click here.

To access the slides from the webinar, click here.

Connect with Shawn:

LinkedIn | Twitter/X | Personal Site | Instagram

Alternate links and other platforms you can watch/listen on:

How To Support The Show

If you want to support me there are 2 ways you can for free

* Give this podcast a 5-star rating on Spotify or Apple Podcasts

* Share this with anyone you think would enjoy this

If you have any questions, please comment below, or you can connect with me on LinkedIn!

If you enjoyed this podcast episode, please consider subscribing to the channel and sharing the episode. Many thanks.

B.U.D.S is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Build. Understand. Discipline. Stillness. “B.U.D.S” is written by me, Dr. Shawn Gill - I’m a pharmacist and Father of two boys. During the day, I work as a deprescribing pharmacist, helping patients get off drugs, safely and effectively. At night, I write this newsletter. B.U.D.S is a community focused on inspiring individuals to take account of their health and wellness, as well as reverse mental health and chronic disease. If you’d like to support this mission, please subscribe below. Much love. SG



Get full access to B.U.D.S at shawngill.substack.com/subscribe
...more
View all episodesView all episodes
Download on the App Store

Deprescribe with Shawn GillBy Shawn Gill